$506.67
-8.74-1.7%
Last update: Oct 7, 5:44 PM
$507.01
-8.40-1.63%
IDEXX Laboratories Inc
IDXXNASDAQ
IDEXX Laboratories (IDXX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
IDEXX Laboratories (IDXX) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $14.69 - $14.94, compared to a consensus EPS estimate of $14.64. IDEXX Laboratories also guided revenue in the range of $4.7B - $4.75B for the period.
Compared to prior guidance, IDEXX Laboratories maintained its EPS outlook from a previous range of $14.45 - $14.9. On the revenue side, the company maintained its revenue forecast from a prior range of $4.67B - $4.76B.
IDEXX Laboratories has issued 17 guidance updates between November 1, 2022 and August 4, 2026. During this period, the company raised its outlook 8 times and lowered it 1 time, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $3.94 | $3.41 | $2.93 | $3.14 |
| Actual | $4.27 | $3.47 | $3.08 | $3.22 |
| Surprise | +8.38% | +1.76% | +5.12% | +2.55% |
| Revenue | ||||
| Estimate | $1.20B | $1.11B | $1.07B | $1.07B |
| Actual | $1.22B | $1.14B | $1.09B | $1.10B |
| Surprise | +1.43% | +2.69% | +1.85% | +3.19% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $3.70 | $3.36 | $3.95 | $4.61 |
| Revenue | ||||
| Consensus | $1.19B | $1.17B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $4.27 | $3.94 | 8.38 % |
| Q1 | May 5, 2026 | $3.47 | $3.41 | 1.76 % |
| Q4 | Feb 2, 2026 | $3.08 | $2.93 | 5.12 % |
| Q3 | Nov 3, 2025 | $3.22 | $3.14 | 2.55 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $1.22B | $1.20B | 1.43 % |
| Q1 | May 5, 2026 | $1.14B | $1.11B | 2.69 % |
| Q4 | Feb 2, 2026 | $1.09B | $1.07B | 1.85 % |
| Q3 | Nov 3, 2025 | $1.11B | $1.07B | 3.19 % |
